Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 5, 2010, Pages 656-661

  Yang, Chun Rong ^a,b   Zhao, Xiu Li ^a   Hu, Hai Yang ^a   Li, Ke Xin ^a   Sun, Xin ^b   Li, Lei ^a   Chen, Da Wei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Box behnken design; Huperzine A; Melt ultrasonication high pressure homogenization; Nanostructured lipid carrier

Indexed keywords

CETYL PALMITATE; EMULSIFYING AGENT; HUPERZINE A; LIPID; MIGLYOL; NANOCOATING; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; PALMITIC ACID DERIVATIVE; PHOSPHATIDYLCHOLINE; SOLUTOL HS 15; SOYBEAN PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; IN VITRO STUDY; MELT ULTRASONICATION HIGH PRESSURE HOMOGENIZATION; MELTING POINT; MORPHOLOGICAL TRAIT; NANOENCAPSULATION; PARTICLE SIZE; ULTRASOUND; ZETA POTENTIAL;

CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; LIPIDS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSTRUCTURES; NEUROPROTECTIVE AGENTS; PARTICLE SIZE; SESQUITERPENES;

EID: 77951747208     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.656     Document Type: Article

References (28)

1. Freitas C., Müller R. H., Eur. J. Pharm. Biopharm., 47, 125-132 (1999).
2. Müller R., Mäder K., Gohla S., Eur. J. Pharm. Biopharm., 50, 161-177 (2000).
3. Yang S. C., Lu L. F., Cai Y., Zhu J. B., Liang B. W., Yang C. Z., J. Controlled Release, 59, 299 (1999).
4. Hu L. D., Tang X., Cui F. D., J. Pharm. Pharmacol., 56, 1527-1535 (2004).
5. Müller R. H., Radtke M., Wissing S. A., Int. J. Pharm., 242, 121-128 (2002).
6. Jenning V., Mäder K., Gohla S. H., Int. J. Pharm., 205, 15-21 (2000).
7. Souto E. B., Wissing S. A., Barbosa C. M., Int. J. Pharm., 278, 71-77 (2004).
8. Yuan H., Wang L. L., Du Y. Z., Colloid Surf. B: Biointerfaces, 58, 157-162 (2007).
9. Hu F. Q., Jiang S. P., Du Y. Z., Colloid Surf. B: Biointerfaces, 45, 167-173 (2005).
10. Chu D. F., Fu X. Q., Liu W. H., Int. J. Pharm., 325, 116-123 (2006).
11. Gao P., Xu H., Ding P. T., Int. J. Pharm., 330, 1-5 (2007).
12. Zhang Z. X., Wang X. D., Chen Q. T., Natl. Med. J. China, 82, 941-944 (2002).
13. Jiang Y. B., Huang C. S., Huang L. A., Clin. Med. China, 18, 802-803 (2002).
14. Joresa K., Mehnerta W., Drechslerb M., J. Controlled Release, 95, 217-227 (2004).
15. Munasur A. P., Pillay V., Chetty D. J., Govender T., Int. J. Pharm., 323, 43-51 (2006).
16. Kramar A., Turk S., Vrecer F., Int. J. Pharm., 256, 43-52 (2003).
17. Venkateswarlu V., Manjunath K., J. Controlled Release, 95, 627-638 (2004).
18. Geze A., Venier-Julienne M. C., Mathieu D., Filmon R., Int. J. Pharm., 178, 257-268 (1999).
19. Leo E., Cameroni R., Forni F., Int. J. Pharm., 180, 23-30 (1999).
20. Chopra S., Patil G. V., Motwani S. K., Eur. J. Pharm. Biopharm., 66, 73-82 (2007).
21. Han F., Li S. M., Yin R., Colloid Surf. A: Physicochem., 315, 1-7 (2008).
22. Jumaa M., Müller B. W., Colloid Polym. Sci., 227, 347-353 (1999).
23. Jenning V., Mäder K., Gohla S. H., Int. J. Pharm., 205, 15-21 (2000).
24. Marcos G. F., Maria J. A., Dolores T., J. Colloid Interface Sci., 285, 590-598 (2005).
25. Castelli F., Puglia C., Sarpietro M. G., Int. J. Pharm., 304, 231-238 (2005).
26. Mu Èhlen A. zur, Mehnert W., Pharmazie, 53, 552-555 (1998).
27. Wong H. L., Reina B., Andrew M. R., Adv. Drug Deliv. Rev., 59, 491-504 (2007).
28. Eduardo R. J., Juliana M. M., Int. J. Pharm., 310, 187-195 (2006).